Question · asked by 1 review

Low dose naldemedine vs higher dose: Adverse events

Population
people with cancer irrespective of whether receiving palliative care and with opioid‐induced bowel dysfunction
Intervention
Low dose naldemedine
Comparison
higher dose
Outcome
Adverse events

Low dose naldemedine showed no clear difference in adverse events compared with higher doses (low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Low dose naldemedine vs higher doses
Adverse events · people with cancer irrespective of whether they are receiving palliative care and with opioid‐induced bowel dysfunction
Low dose naldemedine showed no clear difference in adverse events compared with higher doses (low certainty).
Mu‐opioid antagonists for opioid‐induced bowel dysfunction in people with cancer and people receiving… (2022) · Cochrane Headline outcomes only
RR 0.84 [0.67, 1.06]1 study · 112 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Mu‐opioid antagonists for opioid‐induced bowel dysfunction in people with cancer and people receiving palliative care
2022 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.